Intellia Therapeutics shares owned by Kraematon Investment Advisors
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Kraematon Investment Advisors
from 13F filings
Historical chart of Kraematon Investment Advisors investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Kraematon Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intellia Therapeutics by Kraematon Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $270k | 9.8k | 27.51 |
2023-12-31 | $326k | 11k | 30.49 |
2023-09-30 | $365k | 12k | 31.62 |
2023-06-30 | $511k | 13k | 40.78 |
2023-03-31 | $312k | 8.4k | 37.27 |
2022-12-31 | $196k | 5.6k | 34.89 |
2022-09-30 | $324k | 5.8k | 55.96 |
2022-06-30 | $318k | 6.1k | 51.79 |
2022-03-31 | $446k | 6.1k | 72.64 |
2021-12-31 | $724k | 6.1k | 118.20 |
More positions owned by Kraematon Investment Advisors
View all positions for Kraematon Investment Advisors